| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | DERMIRA INC COM | 80,000 | 1,404,000 | 0.44% | ||
| 52 | AFFIMED N V COM | 100,000 | 1,347,000 | 0.42% | ||
| 53 | CONATUS PHARMACEUTICALS INC | 250,000 | 1,288,000 | 0.41% | ||
| 54 | ESPERION THERAPEUTICS INC | 15,000 | 1,226,000 | 0.39% | Call | |
| 55 | SCYNEXIS INC | 125,000 | 1,099,000 | 0.35% | ||
| 56 | SPARK THERAPEUTICS INC | 17,500 | 1,055,000 | 0.33% | Call | |
| 57 | DICERNA PHARMACEUTICALS INC | 75,000 | 1,046,000 | 0.33% | ||
| 58 | GENESIS HEALTHCARE INC | 150,000 | 990,000 | 0.31% | ||
| 59 | CASTLIGHT HEALTH INC COM CL B | 120,000 | 977,000 | 0.31% | ||
| 60 | SPARK THERAPEUTICS INC | 15,000 | 904,000 | 0.29% | Put | |
| 61 | ENTEROMEDICS INC | 1,075,000 | 667,000 | 0.21% | ||
| 62 | CYMABAY THERAPEUTICS INC | 240,000 | 646,000 | 0.20% | ||
| 63 | NOVADAQ TECHNOLOGIES INC | 50,000 | 606,000 | 0.19% | Call | |
| 64 | Hercules Offshore Inc | 50,000 | 599,000 | 0.19% | ||
| 65 | FLAMEL TECHNOLOGIES SA | 25,000 | 530,000 | 0.17% | Call | |
| 66 | MEI PHARMA INC | 250,000 | 428,000 | 0.14% | ||
| 67 | IMMUNOMEDICS INC | 75,000 | 305,000 | 0.10% | Call | |
| 68 | ZIOPHARM ONCOLOGY INC | 25,000 | 300,000 | 0.09% | Put | |
| 69 | MEI PHARMA INC | 150,000 | 257,000 | 0.08% | Call |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001597549-15-000012, filed 2015.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
